Lisbeth Evered1,2, Brendan Silbert1,2, David A Scott1,2, Henrik Zetterberg3,4, Kaj Blennow3. 1. Centre for Anaesthesia and Cognitive Function, Department of Anaesthesia and Acute Pain Medicine, St. Vincent's Hospital, Melbourne, Australia. 2. Anaesthesia Perioperative and Pain Medicine Unit, Melbourne Medical School, University of Melbourne, Australia. 3. Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Mölndal, Sweden. 4. Department of Molecular Neuroscience, University College London Institute of Neurology, London, England.
Abstract
Importance: Anesthesia and surgery are believed to act on the central nervous system by a fully reversible mechanism innocuous to nerve cells. Evidence that neurological sequelae may follow would challenge this belief and would thereby suggest a need to reassess theories of the mechanism of anesthetic action or the response of the central nervous system to surgery. Objective: To measure 2 biomarkers of neurological injury (neurofilament light and tau) in plasma in a series of timed collections before and after anesthesia and surgery. Design, Setting, and Participants: These 2 related observational studies (CAPACITY and ARCADIAN) recruited patients 60 years and older who were undergoing general anesthesia for surgeries performed within a tertiary hospital. Blood samples were taken immediately before surgical anesthesia was administered and then sequentially after surgery at 30-minute, 6-hour, 24-hour, and 48-hour intervals. Sampling took place from January 2014 to August 2015. Data analysis took place from October 2016 to February 2017. Main Outcomes and Measures: Plasma neurofilament light and tau. Results: A total of 30 patients were enrolled (13 from the CAPACITY study and 17 from the ARCADIAN study). The mean (SD) age was 69.1 (7.0) years, and 18 members (59%) of the participant group were female; 22 (73%) were undergoing joint arthroplasty. Mean neurofilament light increased at each measurement from a combined baseline mean (SD) of 22.3 (20.4) pg/mL to a maximal combined mean (SD) level of 35.1 (28.7) pg/mL, a maximum increase of 67% (95% CI, 45%-89%; P < .001), at 48 hours postoperatively. The level of tau increased significantly from baseline at every measurement, from a combined baseline mean (SD) of 3.1 (1.3) pg/mL to a maximal combined mean (SD) of 10.8 (9.5) pg/mL, a peak increase of 257% (95% CI, 154%-361%; P < .001), at 6 hours postoperatively. After 6 hours, the mean level began to return to baseline but remained elevated after 48 hours. Conclusions and Relevance: Neurofilament light is a specific marker of axonal injury and has been shown to indicate neuronal damage in a number of diseases. Tau proteins are an integral component of axonal integrity, and increased tau indicates neuronal damage. The increases in both neurofilament light and tau over 48 hours after surgery suggest that general anesthesia and surgery may be associated with neuronal damage in the short term. Further investigations will be required to study any association with clinical outcomes. These preliminary findings demand that we question the prevailing assumption that anesthesia and surgery are innocuous, transient, and without injurious changes to the central nervous system.
Importance: Anesthesia and surgery are believed to act on the central nervous system by a fully reversible mechanism innocuous to nerve cells. Evidence that neurological sequelae may follow would challenge this belief and would thereby suggest a need to reassess theories of the mechanism of anesthetic action or the response of the central nervous system to surgery. Objective: To measure 2 biomarkers of neurological injury (neurofilament light and tau) in plasma in a series of timed collections before and after anesthesia and surgery. Design, Setting, and Participants: These 2 related observational studies (CAPACITY and ARCADIAN) recruited patients 60 years and older who were undergoing general anesthesia for surgeries performed within a tertiary hospital. Blood samples were taken immediately before surgical anesthesia was administered and then sequentially after surgery at 30-minute, 6-hour, 24-hour, and 48-hour intervals. Sampling took place from January 2014 to August 2015. Data analysis took place from October 2016 to February 2017. Main Outcomes and Measures: Plasma neurofilament light and tau. Results: A total of 30 patients were enrolled (13 from the CAPACITY study and 17 from the ARCADIAN study). The mean (SD) age was 69.1 (7.0) years, and 18 members (59%) of the participant group were female; 22 (73%) were undergoing joint arthroplasty. Mean neurofilament light increased at each measurement from a combined baseline mean (SD) of 22.3 (20.4) pg/mL to a maximal combined mean (SD) level of 35.1 (28.7) pg/mL, a maximum increase of 67% (95% CI, 45%-89%; P < .001), at 48 hours postoperatively. The level of tau increased significantly from baseline at every measurement, from a combined baseline mean (SD) of 3.1 (1.3) pg/mL to a maximal combined mean (SD) of 10.8 (9.5) pg/mL, a peak increase of 257% (95% CI, 154%-361%; P < .001), at 6 hours postoperatively. After 6 hours, the mean level began to return to baseline but remained elevated after 48 hours. Conclusions and Relevance: Neurofilament light is a specific marker of axonal injury and has been shown to indicate neuronal damage in a number of diseases. Tau proteins are an integral component of axonal integrity, and increased tau indicates neuronal damage. The increases in both neurofilament light and tau over 48 hours after surgery suggest that general anesthesia and surgery may be associated with neuronal damage in the short term. Further investigations will be required to study any association with clinical outcomes. These preliminary findings demand that we question the prevailing assumption that anesthesia and surgery are innocuous, transient, and without injurious changes to the central nervous system.
Authors: Dirk Westermann; Johannes Tobias Neumann; Nils Arne Sörensen; Stefan Blankenberg Journal: Nat Rev Cardiol Date: 2017-04-06 Impact factor: 32.419
Authors: Jeffrey Randall; Erik Mörtberg; Gail K Provuncher; David R Fournier; David C Duffy; Sten Rubertsson; Kaj Blennow; Henrik Zetterberg; David H Wilson Journal: Resuscitation Date: 2012-08-09 Impact factor: 5.262
Authors: Junxia X Tang; Dimitry Baranov; Mary Hammond; Leslie M Shaw; Maryellen F Eckenhoff; Roderic G Eckenhoff Journal: Anesthesiology Date: 2011-10 Impact factor: 7.892
Authors: Niklas Mattsson; Henrik Zetterberg; Shorena Janelidze; Philip S Insel; Ulf Andreasson; Erik Stomrud; Sebastian Palmqvist; David Baker; Cristina A Tan Hehir; Andreas Jeromin; David Hanlon; Linan Song; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Oskar Hansson; Kaj Blennow Journal: Neurology Date: 2016-09-30 Impact factor: 9.910
Authors: Anders Rosén; Nicklas Oscarsson; Andreas Kvarnström; Mikael Gennser; Göran Sandström; Kaj Blennow; Helen Seeman-Lodding; Henrik Zetterberg Journal: Diving Hyperb Med Date: 2019-06-30 Impact factor: 0.887
Authors: Tamara G Fong; Sarinnapha M Vasunilashorn; Edward R Marcantonio; Sharon K Inouye; Long Ngo; Towia A Libermann; Simon T Dillon; Eva M Schmitt; Alvaro Pascual-Leone; Steven E Arnold; Richard N Jones Journal: Ann Neurol Date: 2020-09-15 Impact factor: 10.422
Authors: Elizabeth Mahanna-Gabrielli; Katie J Schenning; Lars I Eriksson; Jeffrey N Browndyke; Clinton B Wright; Deborah J Culley; Lis Evered; David A Scott; Nae Yah Wang; Charles H Brown; Esther Oh; Patrick Purdon; Sharon Inouye; Miles Berger; Robert A Whittington; Catherine C Price; Stacie Deiner Journal: Br J Anaesth Date: 2019-08-19 Impact factor: 9.166
Authors: Stacie Deiner; Mark G Baxter; Joshua S Mincer; Mary Sano; James Hall; Ismail Mohammed; Sid O'Bryant; Henrik Zetterberg; Kaj Blennow; Roderic Eckenhoff Journal: Br J Anaesth Date: 2020-06-11 Impact factor: 9.166
Authors: Keith W VanDusen; Sarada Eleswarpu; Eugene W Moretti; Michael J Devinney; Donna M Crabtree; Daniel T Laskowitz; Marty G Woldorff; Kenneth C Roberts; John Whittle; Jeffrey N Browndyke; Mary Cooter; Frank W Rockhold; Oke Anakwenze; Michael P Bolognesi; Mark E Easley; Michael N Ferrandino; William A Jiranek; Miles Berger Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: N J Ashton; A Leuzy; T K Karikari; N Mattsson-Carlgren; A Dodich; M Boccardi; J Corre; A Drzezga; A Nordberg; R Ossenkoppele; H Zetterberg; K Blennow; G B Frisoni; V Garibotto; O Hansson Journal: Eur J Nucl Med Mol Imaging Date: 2021-03-06 Impact factor: 9.236
Authors: Tyler Ballweg; Marissa White; Margaret Parker; Cameron Casey; Amber Bo; Zahra Farahbakhsh; Austin Kayser; Alexander Blair; Heidi Lindroth; Robert A Pearce; Kaj Blennow; Henrik Zetterberg; Richard Lennertz; Robert D Sanders Journal: Br J Anaesth Date: 2020-11-20 Impact factor: 9.166
Authors: Robert D Sanders; Lenka Craigova; Benjamin Schessler; Cameron Casey; Marissa White; Margaret Parker; David Kunkel; Kaj Blennow; Henrik Zetterberg; Robert A Pearce; Richard Lennertz Journal: Br J Anaesth Date: 2020-11-04 Impact factor: 9.166